Sponsors must rethink ‘primitive’ clinical trial approaches: Phesi
A leader from the clinical development services provider recommends using industry modal values to avoid protocol amendments, enrollment problems and more.
Archives for May 4, 2021
Latest FDA COVID-19-related advice and actions
The US agency continues to keep a watchful eye over the nation’s pandemic response, issuing advice to professionals and taking action where appropriate.
PRA expands COVID-19 pharmacovigilance resources
The CRO is offering an expanded range of post-authorization solutions designed to help developers with treatments and vaccines in their product pipeline